Large-scale testing (Phase 3)Not Yet RecruitingNCT06447701
What this trial is testing
Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis
Who this might be right for
Brain DiseasesIschemic StrokeIschemia+4 more
Zhujiang Hospital 486